Easwaran M, Govindaraj RG, Naderi M, Brylinski M, et al. Evaluating the antibacterial activity of engineered phage capital EF, CyrillicEcSw endolysin against multidrug-resistant Escherichia coli strain Sw1. Int J Antimicrob Agents 2025;65:107395.
PMID: 39612993